Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Chromosome-wide mapping of DNA methylation patterns in normal and malignant prostate cells reveals pervasive methylation of gene-associated and conserved intergenic sequences.

Yegnasubramanian S, Wu Z, Haffner MC, Esopi D, Aryee MJ, Badrinath R, He TL, Morgan JD, Carvalho B, Zheng Q, De Marzo AM, Irizarry RA, Nelson WG.

BMC Genomics. 2011 Jun 13;12:313. doi: 10.1186/1471-2164-12-313.

3.

Genome-wide mapping and characterization of hypomethylated sites in human tissues and breast cancer cell lines.

Shann YJ, Cheng C, Chiao CH, Chen DT, Li PH, Hsu MT.

Genome Res. 2008 May;18(5):791-801. doi: 10.1101/gr.070961.107. Epub 2008 Feb 6.

4.

Methylome-wide Sequencing Detects DNA Hypermethylation Distinguishing Indolent from Aggressive Prostate Cancer.

Bhasin JM, Lee BH, Matkin L, Taylor MG, Hu B, Xu Y, Magi-Galluzzi C, Klein EA, Ting AH.

Cell Rep. 2015 Dec 15;13(10):2135-46. doi: 10.1016/j.celrep.2015.10.078. Epub 2015 Nov 25.

5.

Comparison of methyl-DNA immunoprecipitation (MeDIP) and methyl-CpG binding domain (MBD) protein capture for genome-wide DNA methylation analysis reveal CpG sequence coverage bias.

Nair SS, Coolen MW, Stirzaker C, Song JZ, Statham AL, Strbenac D, Robinson MD, Clark SJ.

Epigenetics. 2011 Jan;6(1):34-44. doi: 10.4161/epi.6.1.13313. Epub 2011 Jan 1.

PMID:
20818161
6.

Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer.

Kim JH, Dhanasekaran SM, Prensner JR, Cao X, Robinson D, Kalyana-Sundaram S, Huang C, Shankar S, Jing X, Iyer M, Hu M, Sam L, Grasso C, Maher CA, Palanisamy N, Mehra R, Kominsky HD, Siddiqui J, Yu J, Qin ZS, Chinnaiyan AM.

Genome Res. 2011 Jul;21(7):1028-41. doi: 10.1101/gr.119347.110.

7.

Effects of sulforaphane and 3,3'-diindolylmethane on genome-wide promoter methylation in normal prostate epithelial cells and prostate cancer cells.

Wong CP, Hsu A, Buchanan A, Palomera-Sanchez Z, Beaver LM, Houseman EA, Williams DE, Dashwood RH, Ho E.

PLoS One. 2014 Jan 22;9(1):e86787. doi: 10.1371/journal.pone.0086787. eCollection 2014.

8.

Rare and frequent promoter methylation, respectively, of TSHZ2 and 3 genes that are both downregulated in expression in breast and prostate cancers.

Yamamoto M, Cid E, Bru S, Yamamoto F.

PLoS One. 2011 Mar 14;6(3):e17149. doi: 10.1371/journal.pone.0017149.

9.

Identification of CpG Sites of SERPINA5 Promoter with Opposite Methylation Patterns in Benign and Malignant Prostate Cells.

Hagelgans A, Jandeck C, Friedemann M, Donchin A, Richter S, Menschikowski M.

Anticancer Res. 2017 Dec;37(12):6609-6618.

PMID:
29187436
10.

Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays.

Kron K, Pethe V, Briollais L, Sadikovic B, Ozcelik H, Sunderji A, Venkateswaran V, Pinthus J, Fleshner N, van der Kwast T, Bapat B.

PLoS One. 2009;4(3):e4830. doi: 10.1371/journal.pone.0004830. Epub 2009 Mar 13.

11.

DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases.

Aryee MJ, Liu W, Engelmann JC, Nuhn P, Gurel M, Haffner MC, Esopi D, Irizarry RA, Getzenberg RH, Nelson WG, Luo J, Xu J, Isaacs WB, Bova GS, Yegnasubramanian S.

Sci Transl Med. 2013 Jan 23;5(169):169ra10. doi: 10.1126/scitranslmed.3005211.

12.

Survey of differentially methylated promoters in prostate cancer cell lines.

Wang Y, Yu Q, Cho AH, Rondeau G, Welsh J, Adamson E, Mercola D, McClelland M.

Neoplasia. 2005 Aug;7(8):748-60.

13.

Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns.

Kirby MK, Ramaker RC, Roberts BS, Lasseigne BN, Gunther DS, Burwell TC, Davis NS, Gulzar ZG, Absher DM, Cooper SJ, Brooks JD, Myers RM.

BMC Cancer. 2017 Apr 17;17(1):273. doi: 10.1186/s12885-017-3252-2.

14.

Dynamic interplay between locus-specific DNA methylation and hydroxymethylation regulates distinct biological pathways in prostate carcinogenesis.

Kamdar SN, Ho LT, Kron KJ, Isserlin R, van der Kwast T, Zlotta AR, Fleshner NE, Bader G, Bapat B.

Clin Epigenetics. 2016 Mar 15;8:32. doi: 10.1186/s13148-016-0195-4. eCollection 2016.

15.

Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer.

Ballestar E, Paz MF, Valle L, Wei S, Fraga MF, Espada J, Cigudosa JC, Huang TH, Esteller M.

EMBO J. 2003 Dec 1;22(23):6335-45.

16.
17.

"Promoter array" studies identify cohorts of genes directly regulated by methylation, copy number change, or transcription factor binding in human cancer cells.

Wang Y, Hayakawa J, Long F, Yu Q, Cho AH, Rondeau G, Welsh J, Mittal S, De Belle I, Adamson E, McClelland M, Mercola D.

Ann N Y Acad Sci. 2005 Nov;1058:162-85. Review.

PMID:
16394135
18.

A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.

Shames DS, Girard L, Gao B, Sato M, Lewis CM, Shivapurkar N, Jiang A, Perou CM, Kim YH, Pollack JR, Fong KM, Lam CL, Wong M, Shyr Y, Nanda R, Olopade OI, Gerald W, Euhus DM, Shay JW, Gazdar AF, Minna JD.

PLoS Med. 2006 Dec;3(12):e486.

19.

Dysregulated methylation at imprinted genes in prostate tumor tissue detected by methylation microarray.

Jacobs DI, Mao Y, Fu A, Kelly WK, Zhu Y.

BMC Urol. 2013 Jul 26;13:37. doi: 10.1186/1471-2490-13-37.

20.

Cloning of mouse Dab2ip gene, a novel member of the RasGTPase-activating protein family and characterization of its regulatory region in prostate.

Chen H, Karam JA, Schultz R, Zhang Z, Duncan C, Hsieh JT.

DNA Cell Biol. 2006 Apr;25(4):232-45.

PMID:
16629596

Supplemental Content

Support Center